Hostname: page-component-89b8bd64d-r6c6k Total loading time: 0 Render date: 2026-05-09T13:52:45.127Z Has data issue: false hasContentIssue false

Are we ready for Taenia solium cysticercosis elimination in sub-Saharan Africa?

Published online by Cambridge University Press:  20 April 2016

MARIA VANG JOHANSEN*
Affiliation:
Section for Parasitology and Aquatic Diseases, Department of Veterinary Disease Biology, Faculty of Health and Medical Sciences, University of Copenhagen, Dyrlægevej 100, DK-1870 Frederiksberg C, Denmark
CHIARA TREVISAN
Affiliation:
Section for Parasitology and Aquatic Diseases, Department of Veterinary Disease Biology, Faculty of Health and Medical Sciences, University of Copenhagen, Dyrlægevej 100, DK-1870 Frederiksberg C, Denmark
SARAH GABRIËL
Affiliation:
Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium
PASCAL MAGNUSSEN
Affiliation:
Section for Parasitology and Aquatic Diseases, Department of Veterinary Disease Biology, Faculty of Health and Medical Sciences, University of Copenhagen, Dyrlægevej 100, DK-1870 Frederiksberg C, Denmark
UFFE CHRISTIAN BRAAE
Affiliation:
Section for Parasitology and Aquatic Diseases, Department of Veterinary Disease Biology, Faculty of Health and Medical Sciences, University of Copenhagen, Dyrlægevej 100, DK-1870 Frederiksberg C, Denmark
*
*Corresponding author: Section for Parasitology and Aquatic Diseases, Department of Veterinary Disease Biology, Faculty of Health and Medical Sciences, University of Copenhagen, Dyrlægevej 100, DK-1870 Frederiksberg C, Denmark. E-mail: mvj@sund.ku.dk

Summary

The World Health Organization announced in November 2014 at the fourth international meeting on ‘the control of neglected zoonotic diseases – from advocacy to action’, that intervention tools for eliminating Taenia solium taeniosis/cysticercosis (TSTC) are in place. The aim of this work was to elucidate theoretical outcomes of various control options suggested for TSTC elimination in sub-Saharan Africa (SSA) over a 4-year period. Our current knowledge regarding T. solium epidemiology and control primarily builds on studies from Latin America. A simple transmission model – built on data from Latin America – has been used to predict the effect of various interventions such as mass treatment of humans, vaccination and treatment of pigs, and health education of communities, potentially leading to change in bad practices and reducing transmission risks. Based on simulations of the transmission model, even a 4-year integrated One Health approach fails to eliminate TSTC from a small community and in all simulations, the prevalence of human taeniosis and porcine cysticercosis start to rise as soon as the programmes end. Our current knowledge regarding transmission and burden of TSTC in SSA is scarce and while claiming to be tool ready, the selection of diagnostic and surveillance tools, as well as the algorithms and stepwise approaches for control and elimination of TSTC remain major challenges.

Information

Type
Special Issue Article
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © Cambridge University Press 2016
Figure 0

Fig. 1. The basic scenario in the model (Kyvsgaard et al.2007) is a small community with 1000 people and 200 pigs (200 families with one pig per family). The prevalence of taeniosis in humans is set at 2% and the prevalence of porcine cysticercosis is 20% based on epidemiological data from Latin America. (A) The effect of a single treatment with praziquantel given to all school-aged children (representing 30% of the population) at month 24 is depicted, assuming a coverage = 100%, and 100% efficacy of the drug. (B) Effect of four treatments with praziquantel, given to all school-aged children (representing 30% of the population) annually for 4 years starting month 24. Coverage = 90%, Efficacy = 100%. (C) Treating 75% of all pigs with oxfendazole (90% efficacious) at yearly intervals for 4 years starting month 24. (D) Vaccination and treatment of 1–9 months old pigs (80% of the pig population) every 6th month for 4 years starting month 24. Coverage 75%, 100% vaccine efficacy and 90% treatment efficacy. (E) Applying health education four times at annual intervals resulting in 50% reduced pig–human and man-to-pig transmission rates due to assumed changed practices in the following 3-month period only. The health education starts from month 24. (F) The scenario depicts the effect of an integrated approach combining (a) four treatments with praziquantel, given to school-aged children (representing 30% of the population) annually for 4 years (coverage = 90%, efficacy = 100%), (b) health education given to the whole population annually for 4 years (50% reduction in transmission rates for 3 months following each intervention) and (c) vaccination and treatment of 1–9 months old pigs given every 6th month for 4 years (80% of the pig population, coverage 75%, 100% vaccine efficacy and 90% treatment efficacy). All interventions start at month 24.